The indigenous COVID-19 vaccine being developed by a partnership between the ICMR and Bharat Biotech generates immune response according to results released in a preprint paper titled ‘A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine- BBV152’.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.